REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Is Six-membered And Includes At Least Nitrogen And Sulfur As Ring Members Hetero Ring Is Six-membered And Includes At Least Nitrogen And Sulfur As Ring MembersHetero Ring Is Six-membered And Includes At Least Nitrogen And Sulfur As Ring Members patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.11/02/06 - 20060247230 - Novel piperidine-substituted indoles The compounds of formula 1 are useful as agonists or antagonists of CCR-3. The present invention is also directed to pharmaceutically acceptable salts thereof, more particularly to provide pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of the compounds of the present ... 11/02/06 - 20060247229 - Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides N-(Sulfonyloxybiarylmethyl)aminocyclopropanecarboxamide derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway. ... 09/21/06 - 20060211687 - Potassium salt of an hiv integrase inhibitor A potassium salt of Compound A is disclosed, wherein Compound A is of formula (1): Compound A is an integrase inhibitor useful for preventing or treating HIV infection, for delaying the onset of AIDS, and for treating AIDS. ... 09/07/06 - 20060199809 - Factor xa compounds and forms and pharmaceutical compositions thereof, and the use thereof as inhibitors of Factor Xa. ... 06/29/06 - 20060142276 - Therapeutic agent for senile dementia D is a group of —(CH2)p—A—(CH2)q—; G is =N—, —CH—, etc.; and Ar is an aromatic heterocyclic group, etc. ... 06/22/06 - 20060135512 - Aminocycloalkanes as dpp-iv inhibitors wherein R1 is as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance. ... 10/13/05 - 20050227969 - Ep4 receptor agonist, compositions and methods thereof This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of ... 07/14/05 - 20050153957 - Beta2-adrenoceptor agonists Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases. ... ### FreshPatents.com Support |